Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy.
Odocha
O
O
Department of Surgery, Howard University College of Medicine, Washington, DC 20060, USA.
Kelly
B
B
Trimble
S
S
Murigande
C
C
Toussaint
R M
RM
Callender
C O
CO
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D003363:Cost Control; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000191:economics* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics* / Q000627:therapeutic use; D007654:Ketoconazole / Q000191:economics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000191:economics* / Q000276:immunology / Q000502:physiology; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000191:economics* / Q000276:immunology / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010976:Platelet Count
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D000410:Alanine Transaminase; D007654:Ketoconazole